XNASMHUA
Market cap8mUSD
Dec 24, Last price
0.34USD
1D
4.51%
1Q
-66.74%
IPO
-96.27%
Name
Meihua International Medical Technologies Co Ltd
Chart & Performance
P/E
0.75
P/S
0.09
EPS
0.45
Div Yield, %
0.00%
Shrs. gr., 5y
3.66%
Rev. gr., 5y
5.10%
Revenues
97m
-6.05%
Net income
12m
+86.22%
CFO
2m
P
Profile
Meihua International Medical Technologies Co., Ltd. engages in the manufacture and marketing of medical consumables in the People's Republic of China. It offers class I, II, and III disposable medical devices. The company's products include non-bottled products, such as brushes and ID bracelets; and polyethylene bottled products, such as eye drop and tablet bottles. It also distributes disposable medical devices sourced from other manufacturers to customers in China. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People's Republic of China. Meihua International Medical Technologies Co., Ltd. operates as a subsidiary of Bright Accomplish Limited.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | ||||||
Revenues | 97,099 -6.05% | 103,346 -0.66% | 104,038 16.82% | |||
Cost of revenue | 79,725 | 86,890 | 78,735 | |||
Unusual Expense (Income) | ||||||
NOPBT | 17,374 | 16,456 | 25,303 | |||
NOPBT Margin | 17.89% | 15.92% | 24.32% | |||
Operating Taxes | 3,458 | 4,714 | 5,278 | |||
Tax Rate | 19.90% | 28.64% | 20.86% | |||
NOPAT | 13,916 | 11,743 | 20,024 | |||
Net income | 11,625 86.22% | 6,243 -70.20% | 20,950 10.00% | |||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | 34,530 | |||||
BB yield | -17.81% | |||||
| Debt | ||||||
Debt current | 7,327 | 6,089 | 5,178 | |||
Long-term debt | 12 | 725 | ||||
Deferred revenue | ||||||
Other long-term liabilities | (725) | |||||
Net debt | (15,721) | (26,592) | (3,912) | |||
| Cash flow | ||||||
Cash from operating activities | 2,276 | (9,163) | (55) | |||
CAPEX | (1,183) | (2,699) | (850) | |||
Cash from investing activities | (12,459) | (8,620) | (834) | |||
Cash from financing activities | 706 | 37,246 | 1,860 | |||
FCF | 5,689 | (15,778) | 10,702 | |||
| Balance | ||||||
Cash | 16,927 | 26,737 | 8,149 | |||
Long term investments | 6,132 | 6,670 | 942 | |||
Excess cash | 18,204 | 28,239 | 3,889 | |||
Stockholders' equity | 103,871 | 95,712 | 97,094 | |||
Invested Capital | 135,965 | 116,123 | 106,018 | |||
ROIC | 11.04% | 10.57% | 21.24% | |||
ROCE | 11.27% | 11.40% | 23.02% | |||
| EV | ||||||
Common stock shares outstanding | 23,940 | 23,411 | 23,600 | |||
Price | 1.48 -82.13% | 8.28 | ||||
Market cap | 35,431 -81.72% | 193,844 | ||||
EV | 20,217 | 167,808 | ||||
EBITDA | 17,845 | 17,020 | 25,925 | |||
EV/EBITDA | 1.13 | 9.86 | ||||
Interest | 251 | 195 | 181 | |||
Interest/NOPBT | 1.44% | 1.18% | 0.71% | |||